Coveo Posts Record Q4 Bookings, Commerce Surges to 60% of New Business
Read source articleWhat happened
Coveo reported Q4 FY26 results with SaaS subscription revenue of $35.9 million, and management highlighted the best fourth quarter new business bookings in company history. Commerce momentum accelerated, driving approximately 60% of new business, including the largest new customer win ever. This performance validates the strategy of partner-led distribution (SAP, Bell) and suggests that the company is converting product interest into measurable revenue. The key profitability test—approximately breakeven adjusted EBITDA for the quarter—appears to have been met, though specific EBITDA figures are not detailed in the release. However, the master report's thesis hinges on net expansion rate (NER) staying above 100%; while Q4 revenue strength is encouraging, NER data has not been disclosed, leaving that risk open.
Implication
Coveo's Q4 results provide the strongest evidence yet that commerce and partner-driven growth can generate meaningful new bookings, which underpins the bull scenario in the master report. The record bookings and large customer win reduce the probability of a near-term miss on the profitability guide, likely compressing the 'prove-it' discount. However, the stock's re-rating potential remains capped until Net Expansion Rate demonstrates improvement above the current 102% level, as expansion is the compound engine for sustained growth. If NER holds or improves in the next quarter, the base and bull cases become more probable, supporting a higher valuation range. For now, the data supports maintaining a constructive stance, but the burden of proof shifts to expansion metrics.
Thesis delta
The Q4 FY26 results materially reduce the probability of the bear case, as record bookings and strong commerce momentum confirm the partner-led growth strategy is gaining traction. The key thesis risk has shifted from top-line sustainability to the Net Expansion Rate, which must hold above 100% to validate expansion-led compounding. If NER improves, the bull scenario (implied value $7.50) becomes more likely; if it slips, the base case ($5.50) remains intact.
Confidence
MODERATE